In 2023, the Chinese pharmaceutical giant Jiangsu Hengrui Pharmaceuticals spent more than 6.1 billion yuan on research and development, representing almost 27 percent of its overall operating income. As the leading developer of oncology medicine, the company's R&D spending increased by more than 400 percent between 2016 and 2022.
Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shanghai Stock Exchange. (April 18, 2024). Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023 [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange. "Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023." Chart. April 18, 2024. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange. (2024). Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange. "Share of Research and Development Expenditure in Overall Operating Revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023." Statista, Statista Inc., 18 Apr 2024, https://www.statista.com/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/
Shanghai Stock Exchange, Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023 Statista, https://www.statista.com/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/ (last visited December 22, 2024)
Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2023 [Graph], Shanghai Stock Exchange, April 18, 2024. [Online]. Available: https://www.statista.com/statistics/1405540/jiangsu-hengrui-pharmaceuticals-randd-expenditure-share/